Logo of SYNERGY-AI Cancer Trial Finder android Application

SYNERGY-AI Cancer Trial Finder

Author Name : SYNERGY-AI Cancer Trial Finder

Operating System : android

License : Free

Rating : Everyone


SYNERGY-AI Cancer Trial Finder Download Links for Android


SYNERGY-AI Cancer Trial Finder Screenshot


About SYNERGY-AI Cancer Trial Finder Android Application

SYNERGY-AI Cancer Trial Finder is a cutting-edge tool that empowers cancer patients to access and stay informed about the latest FDA-approved clinical trials tailored to their specific needs. Leveraging advanced AI technology, the application provides real-time notifications of eligible trials based on individual profiles and cancer genomics. Additionally, it seamlessly integrates AI and mobile tech to connect patients with the most convenient trial sites near their location. The SYNERGY-AI Cancer Trial Finder serves as a comprehensive support system, connecting patients and physicians with the resources they need to fight cancer with access to personalized treatments and guidance.


Application Official Website

https://www.massivebio.com


Application Support Email

[email protected]


Application Main Features

  • AI-driven engine matching patient characteristics with active clinical trials.
  • Real-time notifications of eligible trials based on individual profiles and cancer genomics.
  • Multifaceted approach combining technology and expertise of oncologists.
  • Integrated AI and mobile technology to determine trial eligibility and direct patients to trial sites.
  • Notifications about nearby trial matches based on postcode.
  • Cancer-related information to assist patients throughout their journey.
  • Unique, hassle-free, evidence-based service for cancer patients.
  • Platform for physicians to review clinical trials and refer patients.
  • Connected and supportive pathway to potentially life-saving treatments.
  • Belief that no one should fight cancer alone.


Application Ratings

4.8
1
2
3
4
5



The content is rewritten by Gemini Ai ,Published Date : 15/3/2024 , Modified Date : 15/3/2024